Clinical Trial Update: Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection

View source ↗

Summary

A completed clinical trial evaluating extended out-of-hospital prophylaxis with low-molecular-weight heparin to prevent deep vein thrombosis and pulmonary embol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Lung Cancer
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Dalteparin (dalteparin)
• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: McMaster University | Conditions: Venous Thrombosis, Pulmonary Embolism | Status: COMPLETED